Oric Pharmaceuticals Inc (ORIC) — Long-term Investment Intensity
Oric Pharmaceuticals Inc (ORIC) has a Long-term Investment Intensity of 31.5% as of March 2026. Long-term investments of $137.78 Million represent 31.5% of total assets of $436.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore cash flow conversion of Oric Pharmaceuticals Inc to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oric Pharmaceuticals Inc Long-term Investment Intensity (2021–2025)
This chart shows how Oric Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of March 2026, the intensity stands at 31.5%, reflecting long-term investments of $137.78 Million against total assets of $436.76 Million USD. Explore how well can Oric Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Oric Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Oric Pharmaceuticals Inc from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ORIC market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 26.9% | $110.76 Million | $411.00 Million | ▲ +16.4 pp |
| 2023 | 10.5% | $26.85 Million | $254.69 Million | ▲ +1.8 pp |
| 2022 | 8.8% | $21.95 Million | $250.36 Million | ▼ -5.8 pp |
| 2021 | 14.5% | $43.39 Million | $298.64 Million | — |